Telescope Innovations and AGI SDA Launch Technology Development Collaboration

Executive Summary

• Telescope Innovations Corp. has entered into a Development and Collaboration Agreement with AGI Group’s Synthesis, Digitization, and Automation (AGI SDA) program to co‑develop next‑generation automation‑ and AI‑ready chemical reactor technology.
• The partnership leverages Telescope’s sampling expertise (e.g., DirectInject‑LC™) and aims to integrate it into AGI’s automated reactor platforms, supporting future “Self‑Driving Labs” solutions for biopharma and specialty chemicals.
• The collaboration involves six major bio‑pharmaceutical companies and positions both parties for a significant commercial opportunity, with AGI’s SYNTO platform slated for release in mid‑2027.

Key Details

• Agreement Scope: Joint development of an integrated chemical reactor system that combines Telescope’s high‑quality sampling technology with AGI SDA’s automated laboratory/reactor hardware and control software.
• Strategic Intent: Create a next‑generation, AI‑ready reactor platform that can be incorporated into Self‑Driving Labs (SDLs) for autonomous experiment execution, real‑time analysis, and data‑driven decision making.
• Commercial Opportunity: Target market includes high‑value pharmaceutical and specialty chemical manufacturers; the collaboration is backed by six major bio‑pharma companies seeking accelerated R&D capabilities.
• Existing Deployments: Telescope has already deployed two SDL systems for international biopharmaceutical clients, including Pfizer.
• Future Product Roadmap: AGI’s “SYNTO” platform—an advanced chemistry workstation with digital intelligence—is planned for launch in mid‑2027 and will incorporate the jointly developed sampling and robotics integration.
• Leadership Quotes:
• Henry Dubina, CEO of Telescope Innovations – highlighted the partnership as a means to accelerate R&D, lower costs, and expand market leadership in automated sampling.
• Francis Van der Eycken, Chief Strategy Officer/Managing Director of AGI SDA – described the agreement as the start of a long‑term collaboration to develop novel solutions using the SYNTO platform.

Notable Quotes

“Global players in lab instrumentation and automation, like AGI SDA, recognize Telescope's technology advantages and are actively seeking to work with us on the future of intelligent chemistry,” — Henry Dubina, CEO, Telescope Innovations Corp.

“Telescope Innovations is selected as our strategic partner for the development of the sampling platform and robotics integration… this collaboration agreement … a long‑term partnership to continue developing novel and impactful solutions,” — Francis Van der Eycken, Chief Strategy Officer AGI Group / Managing Director AGI SDA.